Meditor Group Ltd

13F Filings History

Latest 13F report
Q3 2024 - Oct 7, 2024
Value $
$48.1M
Signature - Title
Brian Desmond - Director, Meditor Group Limited
Location
Hamilton, Bermuda
Summary
This page shows a list of all the recent 13F filings made by Meditor Group Ltd. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Meditor Group Ltd reported 4 stock holdings with total value $48.1M as of Q3 2024. Top holdings included EXEL, ESPR, INDA, and EPI.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 4 $48.1M $0 -$10.1M -$10.1M EXEL, ESPR, INDA, EPI 13F-HR 10/7/2024, 10:29 AM
Q2 2024 4 $54.1M $0 -$10M -$10M EXEL, ESPR, INDA, EPI 13F-HR 7/22/2024, 09:05 AM
Q1 2024 4 $68M $0 -$10.4M -$10.4M EXEL, ESPR, INDA, EPI 13F-HR 4/11/2024, 06:43 AM
Q4 2023 4 $80M $0 -$12M -$12M EXEL, ESPR, INDA, EPI 13F-HR 1/4/2024, 09:25 AM
Q3 2023 4 $77.1M $0 -$50.7M -$50.7M EXEL, ESPR, INDA, EPI 13F-HR 10/31/2023, 10:53 AM
Q2 2023 4 $115M $0 -$9.29M -$9.29M EXEL, ESPR, INDA, EPI 13F-HR 7/25/2023, 12:47 PM
Q1 2023 4 $126M $0 -$23.2M -$23.2M EXEL, ESPR, EPI, INDA 13F-HR 4/10/2023, 04:46 PM
Q4 2022 4 $148M $0 -$3.39M -$3.39M EXEL, ESPR, INDA, EPI 13F-HR 1/4/2023, 05:42 PM
Q3 2022 4 $150M $0 -$14.2M -$14.2M EXEL, ESPR, INDA, EPI 13F-HR 11/7/2022, 02:02 PM
Q2 2022 4 $202M $0 -$26.3M -$26.3M EXEL, ESPR, INDA, EPI 13F-HR 7/18/2022, 02:45 PM
Q1 2022 4 $240M $0 -$23.7M -$23.7M EXEL, ESPR, EPI, INDA 13F-HR 4/12/2022, 01:10 PM
Q4 2021 4 $221M +$8.25M -$26.2M -$18M EXEL, ESPR, INDA, EPI 13F-HR 1/5/2022, 11:13 AM
Q3 2021 4 $291M $0 $0 EXEL, ESPR, INDA, EPI 13F-HR 10/14/2021, 04:24 PM
Q2 2021 4 $283M +$2.94M -$10.1M -$7.2M EXEL, ESPR, INDA, EPI 13F-HR 7/12/2021, 10:25 AM
Q1 2021 4 $356M $0 -$42.2M -$42.2M EXEL, ESPR, INDA, EPI 13F-HR 4/9/2021, 12:09 PM
Q4 2020 5 $359M $0 -$7.56M -$7.56M EXEL, ESPR, INDA, ALKS, EPI 13F-HR 1/6/2021, 02:21 PM
Q3 2020 5 $446M $0 -$2.56M -$2.56M EXEL, ESPR, ALKS, INDA, EPI 13F-HR 10/19/2020, 12:09 PM
Q2 2020 6 $477M $0 -$42.5M -$42.5M EXEL, ESPR, ALKS, INDA, EPI 13F-HR 7/14/2020, 02:31 PM
Q1 2020 6 $290M $0 -$8.48M -$8.48M EXEL, ESPR, ALKS, INDA, EPI 13F-HR 4/30/2020, 02:57 PM
Q4 2019 6 $351M $0 -$8.44M -$8.44M EXEL, ESPR, ALKS, INDA, EPI 13F-HR 1/2/2020, 04:41 PM
Q3 2019 9 $411M $0 $0 EXEL, ESPR, ALKS, INDA, EPI 13F-HR 10/31/2019, 01:09 PM
Q2 2019 9 $497M $0 -$9.51M -$9.51M EXEL, ESPR, ALKS, INDA, EPI 13F-HR 7/24/2019, 11:43 AM
Q1 2019 9 $533M +$10M -$49.7M -$39.7M EXEL, ESPR, ALKS, INDA, EPI 13F-HR 4/3/2019, 12:53 PM
Q4 2018 6 $485M +$3.3M -$4.08M -$781K EXEL, ESPR, ALKS, INDA, EPI 13F-HR 1/2/2019, 12:23 PM
Q3 2018 6 $465M $0 $0 EXEL, ESPR, ALKS, EPI, INDA 13F-HR 10/9/2018, 09:43 AM
Q2 2018 6 $512M +$1.59M $0 +$1.59M EXEL, ESPR, ALKS, EPI, INDA 13F-HR 7/19/2018, 01:23 PM
Q1 2018 6 $636M +$19.3M -$38.4M -$19.1M EXEL, ESPR, ALKS, CLDX, EPI 13F-HR 4/20/2018, 01:06 PM
Q4 2017 8 $777M +$1.84M -$28.3M -$26.5M EXEL, ESPR, ALKS, CLDX, SPXU 13F-HR 1/3/2018, 05:16 PM
Q3 2017 8 $659M +$88.1M -$124M -$36.2M EXEL, ESPR, ALKS, CLDX, SPXU 13F-HR 10/17/2017, 09:25 AM
Q2 2017 8 $665M +$56M $0 +$56M EXEL, ALKS, ESPR, SPXU, SDS 13F-HR 7/21/2017, 11:17 AM
Q1 2017 7 $559M +$53M -$52.2M +$845K EXEL, ALKS, SPXU, SDS, EPI 13F-HR 4/24/2017, 11:39 AM
Q4 2016 5 $405M $0 -$9.41M -$9.41M EXEL, ALKS, EPI, INDA, VVUS 13F-HR 2/1/2017, 02:23 PM
Q3 2016 5 $361M $0 $0 EXEL, ALKS, EPI, INDA, VVUS 13F-HR 10/27/2016, 12:16 PM
Q2 2016 5 $246M +$26.9M -$258K +$26.7M EXEL, ALKS, EPI, INDA, VVUS 13F-HR 7/22/2016, 01:58 PM
Q1 2016 3 $126M $0 -$1.73M -$1.73M EXEL, ALKS, VVUS 13F-HR 4/18/2016, 04:38 PM
Q4 2015 4 $209M $0 -$434K -$434K EXEL, ALKS, VVUS, ITEK 13F-HR 1/22/2016, 02:34 PM
Q3 2015 4 $190M +$17.3M $0 +$17.3M EXEL, ALKS, VVUS, ITEK 13F-HR 10/8/2015, 03:00 PM
Q2 2015 3 $145M $0 $0 EXEL, ALKS, VVUS 13F-HR 7/22/2015, 02:03 PM
Q1 2015 3 $119M $0 $0 ALKS, EXEL, VVUS 13F-HR 4/13/2015, 09:19 AM
Q4 2014 3 $96.4M $0 $0 ALKS, EXEL, VVUS 13F-HR 2/9/2015, 12:20 PM
Q3 2014 3 $86.2M $0 -$735K -$735K ALKS, EXEL, VVUS 13F-HR 10/22/2014, 01:08 PM
Q2 2014 3 $133M +$4.06M $0 +$4.06M EXEL, ALKS, VVUS 13F-HR 7/8/2014, 10:30 AM
Q1 2014 3 $128M +$26M $0 +$26M EXEL, ALKS, VVUS 13F-HR 5/8/2014, 10:21 AM
Q4 2013 3 $135M $0 $0 EXEL, ALKS, VVUS 13F-HR 1/21/2014, 10:51 AM